Drug Profile
Epinephrine inhalation - Stella Pharma
Alternative Names: G2B-011Latest Information Update: 02 Apr 2024
Price :
$50
*
At a glance
- Originator G2B Pharma; Shin Nippon Biomedical Laboratories
- Developer Stella Pharma
- Class Anti-infectives; Antiallergics; Antiasthmatics; Bronchodilators; Catecholamines; Ethanolamines; Skin disorder therapies; Small molecules
- Mechanism of Action Alpha adrenergic receptor agonists; Beta-adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Anaphylaxis